Cooperative Agreement UG3DA061594
Award Date 9/30/25
Completion Date 8/31/27
Dollars Obligated $900K
Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
New Mexico, USA
Similar Awards
- This $1,585,991 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a study to evaluate the use of transcranial direct current stimulation (tDCS) combined with cognitive reappraisal training to reduce craving and cue-reactivity in individuals with cocaine use disorder. The study will conduct a double-blind randomized trial with four groups (n=120 total) to assess the synergistic effects of real vs....
- This federal Cooperative Agreement award of $680,100 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is intended to investigate the use of a combined transcranial direct current stimulation (tDCS) and cognitive training intervention as an adjunct treatment for individuals with opioid use disorder (OUD) who are receiving buprenorphine maintenance treatment. The key products and services to be delivered under this award include:...
- This $674,709 Project Grant awarded on July 15, 2025 by the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), supports research aimed at understanding the neural mechanisms underlying the effects of continuous theta burst stimulation (cTBS) on inhibitory control and craving regulation in nicotine addiction. The research, conducted by the University of Missouri System, involves a location control crossover study examining how cTBS...
- The National Institute on Drug Abuse (NIDA), through the Drug Use and Addiction Research Programs (CFDA 93.279), has awarded a $684,694 Cooperative Agreement to New York University (NYU) to develop and evaluate a novel home-based intervention combining transcranial direct current stimulation (tDCS) with mindfulness meditation for the treatment of cannabis use disorder (CUD). The project, titled "Telehealth-Delivered tDCS for Cannabis Addiction Recovery: The C.A.R.E.S. (Cannabis Addiction...
- The Cooperative Agreement award titled "ACTIFY! AN MHEALTH MOOD MANAGEMENT TOOL TO IMPROVE POPULATION-LEVEL SMOKING CESSATION" is funded by the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH). The $893,044 award will fund a randomized controlled trial to evaluate the efficacy of the ACTIFY! mobile health app, which combines behavioral activation therapy with standard smoking cessation support. The goal is to determine if this integrated...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $420,519 to Indiana University to conduct a preliminary clinical trial testing the effects of a non-invasive brain stimulation technique called Temporal Interference (TI) on reducing nicotine cravings and use. The project aims to evaluate whether 60 minutes of TI stimulation targeting the nucleus accumbens or anterior insula can lead to...
- This Cooperative Agreement award of $3,119,619 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) supports research to evaluate the effects of combining contingency management (CM) with deep transcranial magnetic stimulation (deep TMS) for the treatment of cocaine use disorder (CUD). The study aims to target brain circuitry alterations associated with CM response to improve treatment outcomes for individuals with CUD, a population that has seen...
- This Project Grant from the National Institutes of Health National Institute on Drug Abuse will fund Neurobehavioral Research Inc. to provide network synchrony neurofeedback training and evaluation for opioid dependent individuals receiving medication assisted treatment. The $807,960 award, issued on September 30, 2021, will support 12 neurofeedback sessions over 8 weeks to train participants' brains to mimic adaptive changes in resting state brain network synchrony seen with long-term...
- This $1,039,420 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support research to study the neuronal ensembles and circuits involved in the facilitation and disinhibition of opioid and alcohol seeking behaviors. The 5-year project, which begins on June 1, 2025 and runs through February 28, 2030, will employ innovative techniques such as single-nucleus RNA sequencing, spatial sequencing, and in vivo...
- This Cooperative Agreement award is funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The $818,486 award will support the development and validation of the Stimulant Use Disorder Severity Scale (STUDSS), a clinical outcome assessment tool, at sites in Connecticut and California. This work aims to create a psychometrically sound measure to support medication development for...